Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. - Ramos Perez, Jorge M.; Patel, Keyur P.; Loghavi, Sanam; Garcia-Manero, Guillermo; Borthakur, Gautam; Jabbour, Elias; Wierda, William; Pierce, Sherry; Brandt, Mark; Kornblau, Steven; Kadia, Tapan; Daver, Naval; et al. (Leukemia & Lymphoma, 2022)